Literature DB >> 15249230

Expression of a novel cardiac-specific tropomyosin isoform in humans.

Christopher R Denz1, Aruna Narshi, Robert W Zajdel, Dipak K Dube.   

Abstract

Tropomyosins are a family of actin binding proteins encoded by a group of highly conserved genes. Humans have four tropomyosin-encoding genes: TPM1, TPM2, TPM3, and TPM4, each of which is known to generate multiple isoforms by alternative splicing, promoters, and 3' end processing. TPM1 is the most versatile and encodes a variety of tissue specific isoforms. The TPM1 isoform specific to striated muscle, designated TPM1alpha, consists of 10 exons: 1a, 2b, 3, 4, 5, 6b, 7, 8, and 9a/b. In this study, using RT-PCR with adult and fetal human RNAs, we present evidence for the expression of a novel isoform of the TPM1 gene that is specifically expressed in cardiac tissues. The new isoform is designated TPM1kappa and contains exon 2a instead of 2b. Ectopic expression of human GFP.TPM1kappa fusion protein can promote myofibrillogenesis in cardiac mutant axolotl hearts that are lacking in tropomyosin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249230     DOI: 10.1016/j.bbrc.2004.06.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

1.  Tropomyosin isoforms and reagents.

Authors:  Galina Schevzov; Shane P Whittaker; Thomas Fath; Jim Jc Lin; Peter W Gunning
Journal:  Bioarchitecture       Date:  2011-07-01

2.  Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation.

Authors:  Chehade N Karam; Chad M Warren; Sudarsan Rajan; Pieter P de Tombe; David F Wieczorek; R John Solaro
Journal:  J Muscle Res Cell Motil       Date:  2011-01-09       Impact factor: 2.698

3.  Revealing system-level correlations between aging and calorie restriction using a mouse transcriptome.

Authors:  Seong-Eui Hong; Hyoung-Sam Heo; Dae Hyun Kim; Min-Sun Kim; Chul Hong Kim; Jaewon Lee; Mi-Ae Yoo; Byung Pal Yu; Christiaan Leeuwenburgh; Hae Young Chung
Journal:  Age (Dordr)       Date:  2009-07-10

4.  Identification of a novel TPM4 isoform transcript and comparison to the expression of other tropomyosin isoforms in bovine cardiac and skeletal muscles.

Authors:  Syamalima Dube; Lynn Abbott; Samender Randhawa; Yingli Fan; Joseph W Sanger; Jean M Sanger; Bernard J Poiesz; Dipak K Dube
Journal:  Int J Biochem Mol Biol       Date:  2021-02-15

Review 5.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

Review 6.  Pre-mRNA mis-splicing of sarcomeric genes in heart failure.

Authors:  Chaoqun Zhu; Zhilong Chen; Wei Guo
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-05       Impact factor: 5.187

7.  A comprehensive expressed sequence tag linkage map for tiger salamander and Mexican axolotl: enabling gene mapping and comparative genomics in Ambystoma.

Authors:  J J Smith; D K Kump; J A Walker; D M Parichy; S R Voss
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

8.  Top-down targeted proteomics for deep sequencing of tropomyosin isoforms.

Authors:  Ying Peng; Xin Chen; Han Zhang; Qingge Xu; Timothy A Hacker; Ying Ge
Journal:  J Proteome Res       Date:  2012-12-20       Impact factor: 4.466

Review 9.  Investigations into tropomyosin function using mouse models.

Authors:  Ganapathy Jagatheesan; Sudarsan Rajan; David F Wieczorek
Journal:  J Mol Cell Cardiol       Date:  2009-10-14       Impact factor: 5.000

10.  Myofibril-inducing RNA (MIR) is essential for tropomyosin expression and myofibrillogenesis in axolotl hearts.

Authors:  Chi Zhang; Pingping Jia; Xupei Huang; Gian Franco Sferrazza; Gagani Athauda; Mohan P Achary; Jikui Wang; Sharon L Lemanski; Dipak K Dube; Larry F Lemanski
Journal:  J Biomed Sci       Date:  2009-09-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.